8-K - CG Oncology, Inc. Common stock | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 13, 2026, CG Oncology, Inc. (the “Company”) filed Amendment No. 1 to Prospectus (the “Amendment”) with the Securities and Exchange Comm

Other Event

$550.0M$250.0M$250.0M$300.0M

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 5.1 Opinion of Cooley LLP 23.1 Consent of Cooley LLP (included in Exhibit 5.1) 104 Co

Exhibits Only

Exhibits (2)

5.1

EX-5.1

8-K